A Study to Evaluate the Safety, Tolerability, PK and PD of HNC364 Injectable Suspension
Clinical trial NCT05523570 · COMPLETED
Trial details
- NCT number
- NCT05523570
- Sponsor
- Guangzhou Henovcom Bioscience Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-22
- Primary completion
- 2024-04-15
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.